Drugs News and Research

RSS

SLU researchers work to prevent several serious infectious diseases

Saint Louis University researchers are attacking influenza on multiple fronts as they search for a universal vaccine that protects people from the flu virus that often mutates year to year with deadly consequences.

9 Sep 2014

Researchers examine whether new drug offers added benefit for patients with chronic HCV

The drug simeprevir has been available since May 2014 for the treatment of adult patients with chronic hepatitis C infection.

9 Sep 2014

Treatment with xenon gas after head injury reduces extent of brain damage

Treatment with xenon gas after a head injury reduces the extent of brain damage, according to a study in mice.

9 Sep 2014

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at Chicago.

9 Sep 2014

Nearly half of hog workers carry livestock-associated bacteria to home

A new study suggests that nearly half of workers who care for animals in large industrial hog farming operations may be carrying home livestock-associated bacteria in their noses, and that this potentially harmful bacteria remains with them up to four days after exposure.

9 Sep 2014

State highlights: Texas lawmaker proposes '3 strikes' for nursing homes

New Yorker Deadra Malloy was diagnosed with HIV in 1988, but she remained healthy for so long she wasn't completely convinced she was positive.

9 Sep 2014

Ill. fines hospitals for preventable hospital readmissions

Also, a federal lawsuit in California alleges nursing homes overmedicated their residents and seeks repayment. Illinois will be collecting $16.3 million in penalties from 82 hospitals that had too many Medicaid patients readmitted to their hospital, the state said Friday.

9 Sep 2014

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart failure and to reduce hospitalization for heart failure).

9 Sep 2014

FDA approves use of Menactra for booster vaccination against meningococcal disease

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration approved use of Menactra® [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal disease in persons 15 years through 55 years of age.

9 Sep 2014

Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds

Cholera bacteria, and other types of bacteria that cause diarrheal diseases, infect your intestines where they release AB5 protein toxins – that is they have a single toxic A-subunit that is linked to a pentamer of B-subunits that act as the delivery vehicle to transport the A-subunit into the cells.

8 Sep 2014

Chinese study of serogroup 6 S. pneumoniae finds no antibiotic-resistant clones

A survey of serogroup 6 Streptococcus pneumoniae isolates from children in China has identified no antibiotic-resistant clones, leading the authors to speculate that the isolates may be under antibiotic selective pressure.

8 Sep 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).

8 Sep 2014

Non-invasive delivery of drugs for effective pain relief

Individuals who are squeamish about injections or are looking for a way to let collagen penetrate deeper into the skin may soon have a solution that is faster, more effective and painless.

8 Sep 2014

New immuno-oncology drug helps body's own immune system to fend off cancer

According to an August 25 Reuters report, the U.S. Food and Drug Administration is likely to approve Merck & Co.'s highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline.

8 Sep 2014

Researchers examine why stem cells lose their capacity to repair damage as age increases

As we age, stem cells throughout our bodies gradually lose their capacity to repair damage, even from normal wear and tear.

8 Sep 2014

Eating food just before taking TB drug could reduce effectiveness of medicine

The timing of food intake in the early phase of TB treatment could have a negative impact on the effectiveness of TB treatment.

8 Sep 2014

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin).

8 Sep 2014

Scientists apply iPS cell technology to Huntington's disease transgenic monkey model

Creating induced pluripotent stem cells or iPS cells allows researchers to establish "disease in a dish" models of conditions ranging from Alzheimer's disease to diabetes.

8 Sep 2014

Combination miRNA therapy offers promising therapeutic avenue for non-small-cell lung cancer

Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.

8 Sep 2014

Drugs News and Research

SLU researchers work to prevent several serious infectious diseases

Researchers examine whether new drug offers added benefit for patients with chronic HCV

Treatment with xenon gas after head injury reduces extent of brain damage

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Nearly half of hog workers carry livestock-associated bacteria to home

State highlights: Texas lawmaker proposes '3 strikes' for nursing homes

Ill. fines hospitals for preventable hospital readmissions

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

FDA approves use of Menactra for booster vaccination against meningococcal disease

Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds

Chinese study of serogroup 6 S. pneumoniae finds no antibiotic-resistant clones

Canada funds 22 inventive ideas for improving health in low-resource countries

Transparency Life receives SBIR program grant to fund Phase 2a proof-of-concept study for MS

Non-invasive delivery of drugs for effective pain relief

New immuno-oncology drug helps body's own immune system to fend off cancer

Researchers examine why stem cells lose their capacity to repair damage as age increases

Eating food just before taking TB drug could reduce effectiveness of medicine

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Scientists apply iPS cell technology to Huntington's disease transgenic monkey model

Combination miRNA therapy offers promising therapeutic avenue for non-small-cell lung cancer

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News